NaturalShrimp Inc (SHMP) stock: key figures, P/E, revenue and dividend
Consumer Staples · United States · ISIN US63902N1063
NaturalShrimp Inc financials
| Fiscal year | 2025 | 2026 |
|---|---|---|
| Revenue | 202,817.00 USD | – |
| Gross profit | 63,927.00 USD | – |
| Operating income | -6.92 m USD | – |
| EBIT | -10.73 m USD | – |
| Net income | -10.73 m USD | -10.73 m USD |
| Diluted EPS – continuing operations | -0.01 USD | – |
Full history since 2009, charts and your own formulas
This page shows the last two fiscal years. After free sign-up you get the full income statement, balance sheet and cash flow, price and dividend charts, your own formula metrics and a stock screener covering more than 8,000 companies.
About NaturalShrimp Inc
NaturalShrimp Incorporated is in the process of liquidation of its remaining assets. Previously, the company operated as an aquaculture technology company in the United States. The company develops platform technologies to produce aquatic species in an ecologically controlled, high-density environment, fully contained, and independent production facilities. It also owns and operates indoor recirculating Pacific white shrimp production facilities. The company was founded in 2001 and is headquartered in Boca Raton, Florida.
More stocks
- Autonomix Medical, Inc. (AMIX)
- ECO SCIENCE SOLUTIONS, INC. (ESSI)
- HONG YUAN HOLDING GROUP (HGYN)
- CERENOME, INC. (CNSY)
- Decentral Life, Inc. (WDLF)
- Calidi Biotherapeutics, Inc. (CLDI)
- POWERDYNE INTERNATIONAL, INC. (PWDY)
- REVELATION BIOSCIENCES, INC. (REVB)
- Expion360 Inc. (XPON)
- LIBERTY STAR URANIUM & METALS CORP. (LBSR)
- Decoy Therapeutics Inc. (DCOY)
- Tianci International, Inc. (CIIT)
Not investment advice. All data without warranty, price as of 13.11.2026. Details in the risk notice.